ADTX Logo

Aditxt, Inc. (ADTX) 

NASDAQ
Market Cap
$1.18M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
437 of 790
Rank in Industry
237 of 440

Largest Insider Buys in Sector

ADTX Stock Price History Chart

ADTX Stock Performance

About Aditxt, Inc.

Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ …

Insider Activity of Aditxt, Inc.

Over the last 12 months, insiders at Aditxt, Inc. have bought $0 and sold $0 worth of Aditxt, Inc. stock.

On average, over the past 5 years, insiders at Aditxt, Inc. have bought $44,864 and sold $691,140 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1 shares for transaction amount of $20,000 was made by Albanna Amro A. (Chief Executive Officer) on 2022‑07‑19.

List of Insider Buy and Sell Transactions, Aditxt, Inc.

2023-09-07SaleBNP PARIBAS SECURITIES CORP
20,800
12.7911%
$33.23$691,140-88.11%
2022-07-19PurchaseAlbanna Amro A.Chief Executive Officer
1
$20,000.00$20,000-84.78%
2021-06-01PurchaseShabahang ShahrokhCHIEF INNOVATION OFFICER
490
0.0034%
$2.93$1,436-64.24%
2021-06-01PurchaseAlbanna RowenaCHIEF OPERATING OFFICER
3,400
0.0238%
$2.93$9,974-64.24%
2021-06-01PurchaseAlbanna Amro A.CHIEF EXECUTIVE OFFICER
3,400
0.0238%
$2.93$9,974-64.24%
2021-06-01PurchaseRunge Jeffrey W.director
10,000
0.07%
$2.93$29,344-64.24%
2021-05-27PurchaseShabahang ShahrokhCHIEF INNOVATION OFFICER
185
0.0013%
$2.70$500-59.62%
2021-05-26PurchaseFarley Thomas JPRINCIPAL ACCOUNTING OFFICER
2,500
0.0172%
$2.68$6,700-59.70%
2021-05-25PurchaseShabahang ShahrokhCHIEF INNOVATION OFFICER
417
0.0026%
$2.39$998-58.65%
2021-05-25PurchasePankovcin CorinneCHIEF FINANCIAL OFFICER
4,220
0.0279%
$2.56$10,803-58.65%

Insider Historical Profitability

<0.0001%
Shabahang ShahrokhCHIEF INNOVATION OFFICER
1016098
18.8562%
$0.2230
Albanna RowenaCHIEF OPERATING OFFICER
751620
13.9481%
$0.2210
Pankovcin CorinneCHIEF FINANCIAL OFFICER
114220
2.1196%
$0.2210
Runge Jeffrey W.director
12500
0.232%
$0.2210
Farley Thomas JPRINCIPAL ACCOUNTING OFFICER
2500
0.0464%
$0.2210

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders